Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma.
Zheng ZR, Ku HY, Chen KC, Chiang CJ, Wang CL, Chen CY, Tsai CM, Huang MS, Yu CJ, Chen JS, Chou TY, Lee WC, Wang CC, Liu TW, Hsia JY, Chang GC.
Zheng ZR, et al. Among authors: ku hy.
Front Oncol. 2023 Mar 17;13:1063695. doi: 10.3389/fonc.2023.1063695. eCollection 2023.
Front Oncol. 2023.
PMID: 37007097
Free PMC article.